NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

Just 61% of hospitals surveyed evaluated models for accuracy on their own data, and less than half evaluated the models for ...

The warning ties breast, colorectum, esophagus, liver, mouth (oral cavity), throat (pharynx) and voice box (larynx), cancers to alcohol consumption, claiming that in 2019, there were an estimated ...

Vensana Capital recently announced that it has closed a $425 million Fund III for continued investment in innovative medtech ...

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Another new year, another half-billion-biobuck transaction between Insilico Medicine and the Italian drugmaker Menarini Group ...

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

OXcan was founded in 2020 by Dr. Peter Jianrui Liu and Dr. Andreas Halner to advance early cancer detection using liquid biopsy.

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

Leading private capital deals today include Blackstone's $300 million investment in DDN and a B Capital-led $275 million ...

Venture capital firm Vensana Capital, headquartered in Minneapolis, has closed a $425 million fund to further fuel medtech startups, some of which are in the Twin Cities. Founded in 2019, Vensana ...